“I think people should be aware that there is a potential for this to happen ... .”

— Russell Katz of the FDA, commenting on the possibilities for adverse events following the use of dermal fillers, “Allergan’s Botox, Myobloc from Solstice under ‘review’ by FDA,” pp. 1, 6.